Clinical context: bone atrophy and the limitations of conventional implants

Implant rehabilitation in areas with advanced bone resorption or superficial anatomical structures, such as the inferior alveolar nerve or the maxillary sinus, constitutes a major clinical challenge. While conventional length dental implants (CLDI) are recognized for their long-term success, their implementation in these situations often requires invasive complementary procedures: bone grafts, sinus lifts, or vertical augmentations. These interventions systematically increase costs, treatment duration, and the risks of surgical complications. In this context, short dental implants (SDI), defined by authors as having a length < 8 mm or ≤ 6 mm, appear as a promising alternative to reduce the invasiveness of the management and improve patient comfort.

Study objective and problem statement

Given the need to validate these less invasive protocols, this study is part of an evaluation of bone stability, surgical techniques, and peri-implant health. The objective is to document the clinical longevity, tissue health, as well as the functional efficacy of prosthetic rehabilitations supported by short implants. By avoiding the use of biomaterials or anatomical remodeling, the study seeks to confirm whether the use of SDIs effectively reduces morbidity while maintaining clinical results comparable to traditional reconstruction protocols.

Analysis methodology

This review is based on an umbrella review and a meta-analysis of clinical success outcomes, synthesizing data from multicenter randomized controlled trials (RCTs) and split-mouth studies.

• Design and population: The analysis focuses on the rehabilitation of atrophied posterior areas (mandible or maxilla), particularly in situations of proximity to the inferior alveolar nerve or the maxillary sinus.
• Experimental groups:
  • Short implants (SDI): defined by a length < 8 mm or ≤ 6 mm.
  • Conventional implants (CLDI): lengths of 10 mm, 11 mm or between 11 and 15 mm.
• Protocol and interventions: For the CLDI group, implantation often requires complementary surgical procedures such as maxillary sinus lift, bone grafts or vertical bone augmentation. Conversely, SDIs are placed according to standard protocols without systematic use of reconstruction biomaterials.
• Evaluation criteria: Long-term performance analysis is based on device survival rates and the evolution of radiographic bone loss.
• Timeline: Compiled data allows for evaluation over follow-up periods of 1 year, 3 years, and 10 years.

Summary of clinical performance: Short vs. conventional implants

Data compiled from randomized clinical trials (RCTs) and meta-analyses report comparable survival rates and bone stability between short dental implants (SDI) and conventional length dental implants (CLDI), even over the long term.

The authors highlight compelling results regarding the clinical longevity and functional efficacy of SDI-supported rehabilitations:

• 10-year stability: Studies by Sahrmann et al. (2023), Thoma et al. (2024) and Guljé et al. (2024) confirm the performance of 6 mm implants in posterior areas, with results equivalent to 11-15 mm implants combined with sinus floor elevation.
• Medium-term follow-up (3 years): Menchini-Fabris et al. (2024) report similar efficacy for single crowns on 6 mm implants compared to those on 10 mm.
• Reduction in morbidity: The use of short devices avoids surgical complications related to complex bone reconstructions, while significantly reducing treatment time and cost.

Recent meta-analyses (Ravidà et al. 2024, Papaspyridakos et al. 2018) validate these observations in various clinical scenarios, particularly in the presence of advanced bone resorption or proximity to sensitive anatomical structures such as the inferior alveolar nerve or the maxillary sinus.

Clinical relevance analysis of short implants

The synthesized data in this study confirm that short dental implants (SDI), defined here as ≤ 6 mm, represent a serious alternative to conventional dental implants (CLDI) associated with bone grafts. Clinically, this means that the management of atrophied mandibles or posterior maxillary sectors no longer systematically requires invasive procedures. Avoiding sinus lifts or vertical augmentations not only reduces treatment costs and duration, but also minimizes post-operative morbidity for the patient.

La littérature récente citée, notamment les données à 10 ans de Sahrmann (2023) et Thoma (2024), renforce la crédibilité des implants de 6 mm. Ces dispositifs affichent des taux de survie et une stabilité osseuse comparables aux protocoles standards, malgré des volumes osseux initiaux réduits. Le point de vigilance reste la définition hétérogène de l'implant "court" dans la littérature (allant de < 8 mm à ≤ 6 mm), ce qui peut complexifier la standardisation des protocoles au cabinet.

The limitations of this analysis lie in the need to maintain rigorous long-term monitoring of peri-implant health, as bone loss, even minimal, has a proportionally greater impact on a 6 mm anchorage than on an implant of 10 mm or more. Nevertheless, recent meta-analyses (Ravidà 2024) validate this approach as a predictable solution in complex clinical scenarios.

Data synthesis

Compiled meta-analyses, including robust 10-year follow-ups (Thoma et al., Sahrmann et al.), confirm that short implants (≤ 6 mm) display survival rates and marginal bone stability comparable to conventional implants (≥ 10 mm) associated with grafting. This approach drastically reduces surgical complications and post-operative morbidity without compromising prosthetic longevity.

In concrete terms, for the practitioner:

• Simplify your treatment plans: the use of 6 mm implants avoids complex sinus lifts or vertical augmentations in atrophied posterior sectors, thus securing the alveolar nerve.
• Optimize the cost/benefit ratio: you reduce biomaterial costs, the number of interventions, and the total rehabilitation time, making the treatment more accessible and less invasive for the patient.
• Secure your long-term results: with clinical feedback validated over a decade, the short implant is no longer a technical compromise but a first-line therapeutic solution.

Technical lexicon of the study

Short Dental Implants (SDIs): Reduced-length devices (defined by authors between < 8 mm and ≤ 6 mm) indicated for alveolar ridges presenting severe resorption in order to avoid invasive procedures.

Conventional Length Dental Implants (CLDIs): Standard length implants whose placement in atrophied areas frequently requires additional bone reconstruction oral surgery.

Bone Grafting: Bone grafting technique used to compensate for advanced resorption, although it may increase cost, treatment time, and the rate of surgical complications.

Maxillary Sinus Lift: Maxillary sinus floor elevation procedure designed to increase the available bone height for implantation in the posterior superior sectors.

Vertical Bone Augmentation: Reconstructive surgery aimed at increasing the vertical dimension of a resorbed alveolar ridge to allow the anchoring of conventional-sized implants.

Biomaterials: Substitute materials used for the reconstruction of lost bone tissue, making it possible to avoid complex remodeling of anatomical structures or autogenous harvesting.

Information intended for healthcare professionals. This content may contain errors or truncated summaries. We recommend always verifying with the original source article. Delynov disclaims all responsibility regarding the use of this information. This document is not intended for patients or the general public.